Karuna Therapeutics
Clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions.
Launch date
Employees
Market cap
AUD19.5b
Enterprise valuation
AUD17.5b (Public information from Mar 2024)
Share price
$329.82999 KRTX
Boston Massachusetts (HQ)
Authorizing premium user...